Cargando…
Real-World Use of Androgen-Deprivation Therapy: Intensification Among Older Canadian Men With de Novo Metastatic Prostate Cancer
BACKGROUND: Despite the wealth of evidence demonstrating the efficacy of treatment intensification beyond androgen-deprivation therapy (ADT) among patients with de novo metastatic castration-sensitive prostate cancer (mCSPC), little is known of its real-world use. This study examined the real-world...
Autores principales: | Wallis, Christopher J D, Malone, Shawn, Cagiannos, Ilias, Morgan, Scott C, Hamilton, Robert J, Basappa, Naveen S, Ferrario, Cristiano, Gotto, Geoffrey T, Fernandes, Ricardo, Niazi, Tamim, Noonan, Krista L, Saad, Fred, Hotte, Sebastien J, Hew, Huong, Chan, Katherine F Y, Wyllie, Laura Park, Shayegan, Bobby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678925/ https://www.ncbi.nlm.nih.gov/pubmed/34926988 http://dx.doi.org/10.1093/jncics/pkab082 |
Ejemplares similares
-
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
por: Wallis, Christopher J. D., et al.
Publicado: (2021) -
Patterns of care for non‐metastatic castration‐resistant prostate cancer: A population‐based study
por: Malone, Shawn, et al.
Publicado: (2022) -
Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report
por: Chandhoke, Gursimran, et al.
Publicado: (2018) -
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022) -
Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE
por: Gong, Jun, et al.
Publicado: (2022)